Editorial: Trajectory of soluble programmed cell death protein-1 and ligand-1 in HBV-infected individuals treated with pegylated interferon-implications for stopping rules and the HBV cure programme. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/apt.18142
PubMed Identifier: 39021047
Publication URI: http://europepmc.org/abstract/MED/39021047
Type: Journal Article/Review
Volume: 60
Parent Publication: Alimentary pharmacology & therapeutics
Issue: 5
ISSN: 0269-2813